Direct GDP-KRASG12C inhibitors and mechanisms of resistance: the tip of the iceberg

医学 克拉斯 冰山 癌症研究 内科学 药理学 癌症 物理 海冰 结直肠癌 气象学
作者
Joshua C. Rosen,Adrian G. Sacher,Ming‐Sound Tsao
出处
期刊:Therapeutic Advances in Medical Oncology [SAGE Publishing]
卷期号:15 被引量:10
标识
DOI:10.1177/17588359231160141
摘要

Kirsten rat sarcoma viral oncogene homolog mutations are observed in 25% of lung adenocarcinoma and 40% of these are G12C mutations. Historically, no approved targeted agents were available for patients with any KRAS mutation, and response rates to standard-of-care therapies were suboptimal. Newly developed inhibitors directed toward KRASG12C have been successful in clinical trials with overall response rates ranging between 32% and 46%, and two FDA approvals were granted in May 2021 and December 2022 as second-line or later monotherapies. However, rapid tumor resistance complicates their use as a monotherapy. With the rapid development of this novel class of inhibitors, it is important to discern the different types of tumor resistance that may arise and how each can differently contribute to tumor growth and survival. G12C inhibitor resistance is under investigation and combinations of therapies with G12C inhibitors have been proposed. Much of this insight is gleaned from preclinical investigations, as our knowledge of clinical resistance is in its infancy. In this review, we summarize the preclinical development of KRASG12C inhibitors, their clinical evaluations, different types of resistance mechanisms to these compounds, and ways of overcoming them. Finally, we underscore the importance of basic and translational investigations of these molecules in a landscape where their clinical evaluations garner the most attention, and we set the stage for what is to come.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
冷艳招牌完成签到,获得积分10
1秒前
光子完成签到,获得积分10
1秒前
2秒前
欢020完成签到,获得积分10
2秒前
2秒前
2秒前
风笛发布了新的文献求助10
2秒前
cpxliteratur完成签到,获得积分10
3秒前
3秒前
4秒前
pojian完成签到,获得积分10
4秒前
4秒前
4秒前
4秒前
HJC发布了新的文献求助10
5秒前
5秒前
CipherSage的应助被cullen_zhou采纳,获得10
5秒前
Hdk发布了新的文献求助10
5秒前
6秒前
月123发布了新的文献求助10
7秒前
阿白发布了新的文献求助10
7秒前
饼饼完成签到 ,获得积分10
8秒前
8秒前
杂粮米发布了新的文献求助10
8秒前
FashionBoy的应助被欣喜若灵采纳,获得10
8秒前
隐形曼青的应助被jc哥采纳,获得10
9秒前
卡卡西西西完成签到,获得积分10
9秒前
liujun完成签到,获得积分10
9秒前
不会画画完成签到,获得积分10
9秒前
吕曼完成签到,获得积分10
9秒前
liuzhanyu发布了新的文献求助10
10秒前
哈哈的应助被洋芋大侠采纳,获得10
10秒前
CAOHOU的应助被pw采纳,获得10
11秒前
柳贯一发布了新的文献求助10
11秒前
文静听南完成签到 ,获得积分10
11秒前
11秒前
超级拉瓦锡完成签到,获得积分10
11秒前
12秒前
chiyudoubao完成签到,获得积分10
12秒前
xx发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181155
求助须知:如何正确求助?哪些是违规求助? 9571140
关于积分的说明 21816740
捐赠科研通 7777528
什么是DOI,文献DOI怎么找? 3433436
关于科研通互助平台的介绍 2557664
邀请新用户注册赠送积分活动 2479482